Commercialization of Intellectual Property

Invivoscribe is a world leader commercializing intellectual property in the fields of personalized molecular diagnostics and personalized molecular medicine.

We are the world leader commercializing intellectual property covering molecular diagnostics in the areas of hematopathology and hematology/oncology. While we are currently developing a number of new products with proven clinical value, we welcome learning of new licensing opportunities. We specialize in developing, commercializing, and adding value to intellectual property, and we have developed and maintain mutually beneficial relationships with all of our business partners.

A History of Working in a Collaborative Fashion with World Leaders and Organizations

We work in a collaborative fashion with colleagues from around the world and dedicate resources to participate in efforts to commercialize, standardize, and harmonize test development and performance.

In an effort to arrive at solutions that benefit our customers and improve the quality of healthcare worldwide, we consistently and diligently work with regulatory bodies and agencies.

Our focus is on development of standardized products and technologies that reduce the complexity of scientific and business processes. We are dedicated to achieving maximum value from technologies and intellectual property for Invivoscribe, our customers, licensors, and business partners.